EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review

Marianna Pellegrini iD, Fabio Dario Merlo, Elena Agnello, Taira Monge, Andrea Devecchi, Valentina Casalone iD, Filippo Montemurro iD, Ezio Ghigo iD, Anna Sapino iD, Simona Bo iD

Nutrients · 01.01.2023 · 15 (1) · 226

DOI: 10.3390/nu15010226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 01.01.2023. Verfasst von Marianna Pellegrini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, University of Torino, 10126 Torino, Italy. Hauptthemen laut MEDLINE: Dysgeusia, Breast Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is the most common cancer worldwide. Chemotherapy (CT) is essential for the treatment of BC, but is often accompanied by several side effects, including taste alterations, due to different mechanisms. Although dysgeusia is usually underestimated by clinicians, it is considered very worrying and disturbing by cancer patients undergoing CT, because it induces changes in dietary choices and social habits, affecting their physical and psychological health, with a profound impact on their quality of life. Several strategies and therapies have been proposed to prevent or alleviate CT-induced dysgeusia. This review aimed to evaluate the available evidence on prevalence, pathophysiological mechanisms, clinical consequences, and strategies for managing dysgeusia in BC patients receiving CT. We queried the National Library of Medicine, the Cochrane Library, Excerpta Medica dataBASE, and the Cumulative Index to Nursing and Allied Health Literature database, performing a search strategy using database-specific keywords. We found that the literature on this topic is scarce, methodologically limited, and highly heterogeneous in terms of study design and criteria for patient inclusion, making it difficult to obtain definitive results and make recommendations for clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysgeusiaBreast NeoplasmsHumansFemaleQuality of LifeDiet

Stichwörter der Autor:innen

breast cancerchemotherapydysgeusiadysosmiataste alterations

Autor:innen und Institutionen

  • Department of Medical Sciences, University of Torino, 10126 Torino, Italy.
  • Dietetic and Clinical Nutrition Unit, Città della Salute e della Scienza Hospital, 10126 Torino, Italy.
  • University of Gastronomic Sciences, 12042 Pollenzo, Italy.
  • Clinical Nutrition and Dietetics Unit, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Breast Unit, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Pathology Division, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.

ORCID-Profile: Marianna Pellegrini, Valentina Casalone, Filippo Montemurro, Ezio Ghigo, Anna Sapino, Simona Bo

Zitieren

APA

Pellegrini, M., Merlo, F. D., Agnello, E., Monge, T., Devecchi, A., Casalone, V., Montemurro, F., Ghigo, E., Sapino, A., & Bo, S. (2023). Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review. Nutrients, 15(1), 226. https://doi.org/10.3390/nu15010226

Vancouver

Pellegrini M, Merlo FD, Agnello E, Monge T, Devecchi A, Casalone V, et al. Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review. Nutrients. 2023;15(1):226. doi:10.3390/nu15010226

BibTeX
@article{Pellegrini2023,
  author = {Pellegrini, Marianna and Merlo, Fabio Dario and Agnello, Elena and Monge, Taira and Devecchi, Andrea and Casalone, Valentina and Montemurro, Filippo and Ghigo, Ezio and Sapino, Anna and Bo, Simona},
  title = {Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {226},
  doi = {10.3390/nu15010226}
}
Kostenlos starten →